Immunocompromised patients and COVID-19: how do we protect those most at risk?

被引：3
作者：
Schneider, Jochen [1 ]
Erber, Johanna [1 ]
Renders, Lutz [2 ]
Spinner, Christoph D. [1 ]
机构：
[1] Univ Hosp Klinikum Rechts der Isar, Sch Med, Dept Internal Med 2, Infect Dis, Munich, Germany
[2] Univ Hosp Klinikum Rechts der Isar, Sch Med, Dept Internal Med 2, Nephrol, Munich, Germany
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2024年 / 22卷 / 1-3期
关键词：
COVID-19; immunosuppression; risk for severe COVID-19; ORGAN TRANSPLANT RECIPIENTS;
D O I：
10.1080/14787210.2023.2296067
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 15 条
  • [1] Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
    Brill, Livnat
    Rechtman, Ariel
    Zveik, Omri
    Haham, Nitzan
    Oiknine-Djian, Esther
    Wolf, Dana G.
    Levin, Netta
    Raposo, Catarina
    Vaknin-Dembinsky, Adi
    [J]. JAMA NEUROLOGY, 2021, 78 (12) : 1510 - 1514
  • [2] Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies
    Calderon-Parra, Jorge
    Munez-Rubio, Elena
    Fernandez-Cruz, Ana
    Cristina Garcia-Sanchez, Maria
    Maderuelo-Gonzalez, Esther
    Lopez-Dosil, Marcos
    Calvo-Salvador, Marina
    Banos-Perez, Isolina
    Valle-Falcones, Manuel
    Ramos-Martinez, Antonio
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 74 (10) : 1786 - 1794
  • [3] Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model
    Driouich, Jean-Selim
    Bernadin, Ornellie
    Touret, Franck
    de Lamballerie, Xavier
    Nougairede, Antoine
    [J]. ANTIVIRAL RESEARCH, 2023, 215
  • [4] Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study
    Hall, Victoria G.
    Solera, Javier T.
    Al-Alahmadi, Ghadeer
    Marinelli, Tina
    Cardinal, Heloise
    Poirier, Charles
    Huard, Genevieve
    Prasad, G. V. Ramesh
    De Serres, Sacha A.
    Isaac, Debra
    Mainra, Rahul
    Lamarche, Caroline
    Sapir-Pichhadze, Ruth
    Gilmour, Susan
    Humar, Atul
    Kumar, Deepali
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (33) : E1155 - E1163
  • [5] Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients
    Mikulska, Malgorzata
    Sepulcri, Chiara
    Dentone, Chiara
    Magne, Federica
    Balletto, Elisa
    Baldi, Federico
    Labate, Laura
    Russo, Chiara
    Mirabella, Michele
    Magnasco, Laura
    Di Grazia, Carmen
    Ghiggi, Chiara
    Raiola, Anna Maria
    Giacobbe, Daniele Roberto
    Vena, Antonio
    Beltramini, Sabrina
    Bruzzone, Bianca
    Lemoli, Roberto M.
    Angelucci, Emanuele
    Bassetti, Matteo
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 77 (02) : 280 - 286
  • [6] Temporary reduction of immunosuppression enhances production of anti-S antibody against severe acute respiratory syndrome coronavirus 2 after vaccination in kidney transplant recipients
    Miura, Masayoshi
    Fukumoto, Maiko
    Komatsu, Natsumi
    Shuto, Reimi
    Harada, Hiroshi
    Sasaki, Hajime
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (12) : 1505 - 1510
  • [7] Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19): The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study
    Mukae, Hiroshi
    Yotsuyanagi, Hiroshi
    Ohmagari, Norio
    Doi, Yohei
    Sakaguchi, Hiroki
    Sonoyama, Takuhiro
    Ichihashi, Genki
    Sanaki, Takao
    Baba, Keiko
    Tsuge, Yuko
    Uehara, Takeki
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) : 1403 - 1411
  • [8] Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients
    Najjar-Debbiny, Ronza
    Gronich, Naomi
    Weber, Gabriel
    Khoury, Johad
    Amar, Maisam
    Stein, Nili
    Goldstein, Lee Hilary
    Saliba, Walid
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E342 - E349
  • [9] Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge
    Piccicacco, Nicholas
    Zeitler, Kristen
    Ing, Austin
    Montero, Jose
    Faughn, Jonathan
    Silbert, Suzane
    Kim, Kami
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (10) : 2693 - 2700
  • [10] Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
    Rabascall, Carlos X.
    Lou, Becky X.
    Navetta-Modrov, Brianne
    Hahn, Stella S.
    [J]. BMJ CASE REPORTS, 2021, 14 (08)
12